BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36369472)

  • 21. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
    Tian Q; Gao H; Zhao W; Zhou Y; Yang J
    Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nomogram based on autophagy related genes for predicting the survival in melanoma.
    Deng G; Wang W; Li Y; Sun H; Chen X; Zeng F
    BMC Cancer; 2021 Nov; 21(1):1258. PubMed ID: 34809598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
    Liu J; Lu J; Li W
    Front Immunol; 2021; 12():738068. PubMed ID: 34630418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction and validation of a novel prognostic signature for uveal melanoma based on five metabolism-related genes.
    Zhao H; Chen Y; Shen P; Gong L
    Math Biosci Eng; 2021 Sep; 18(6):8045-8063. PubMed ID: 34814288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma.
    Liang L; Mai S; Mai G; Chen Y; Liu L
    Front Endocrinol (Lausanne); 2022; 13():882431. PubMed ID: 35957812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma.
    Guo S; Chen J; Yi X; Lu Z; Guo W
    Front Immunol; 2022; 13():985051. PubMed ID: 36248853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and Validation of an Immune-Related Gene Pair Signature in Skin Cutaneous Melanoma.
    Xie R; Dong S; Jiang J; Yang C; Li L; Zhao S; Li Y; Wang C; Li S; Xiao Y; Chen L
    Clin Cosmet Investig Dermatol; 2020; 13():973-986. PubMed ID: 33364806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a survival-related signature for sarcoma patients through integrated transcriptomic and proteomic profiling analyses.
    Zhang B; Yang L; Wang X; Fu D
    Gene; 2021 Jan; 764():145105. PubMed ID: 32882333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Novel Oxidative Phosphorylation-Associated Gene Signature for Prognosis Prediction in Patients with Hepatocellular Carcinoma.
    Chen W; Yang Z; Chen Y
    Dis Markers; 2022; 2022():3594901. PubMed ID: 36105252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overcoming intratumoural heterogeneity for reproducible molecular risk stratification: a case study in advanced kidney cancer.
    Lubbock ALR; Stewart GD; O'Mahony FC; Laird A; Mullen P; O'Donnell M; Powles T; Harrison DJ; Overton IM
    BMC Med; 2017 Jun; 15(1):118. PubMed ID: 28648142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma.
    Brooks SA; Brannon AR; Parker JS; Fisher JC; Sen O; Kattan MW; Hakimi AA; Hsieh JJ; Choueiri TK; Tamboli P; Maranchie JK; Hinds P; Miller CR; Nielsen ME; Rathmell WK
    Eur Urol; 2014 Jul; 66(1):77-84. PubMed ID: 24613583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time to recurrence and survival in serous ovarian tumors predicted from integrated genomic profiles.
    Mankoo PK; Shen R; Schultz N; Levine DA; Sander C
    PLoS One; 2011; 6(11):e24709. PubMed ID: 22073136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An autophagy-related prognostic signature associated with immune microenvironment features of uveal melanoma.
    Zheng Z; Zhang L; Tu Z; Deng Y; Yin X
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33682883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma.
    Liu X; Wang J
    Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
    Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
    World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and validation of a prognostic model for melanoma patients with 9 ferroptosis-related gene signature.
    Chen Y; Guo L; Zhou Z; An R; Wang J
    BMC Genomics; 2022 Mar; 23(1):245. PubMed ID: 35354376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and validation of a ferroptosis-related gene signature for predicting survival in skin cutaneous melanoma.
    Ping S; Wang S; Zhao Y; He J; Li G; Li D; Wei Z; Chen J
    Cancer Med; 2022 Sep; 11(18):3529-3541. PubMed ID: 35373463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma.
    Zhou J; Liu G; Wu X; Zhou Z; Li J; Ji Z
    Dis Markers; 2021; 2021():8863799. PubMed ID: 33510822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
    Li X; Pasche B; Zhang W; Chen K
    JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma.
    Ma W; Zhong M; Liu X
    Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34402862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.